Secondary prevention clinics for coronary heart disease: Randomised trial of effect on health

British Medical Journal

Volumn 316, Issue 7142, 1998, Pages 1434-1437

  Campbell, Neil C ^a   Thain, Joan ^b   Deans, H George ^a   Ritchie, Lewis D ^a   Rawles, John M ^c   Squair, Janet L ^c  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b Denburn Health Centre   (United Kingdom)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; FEMALE; FOLLOW UP; GENERAL PRACTICE; HEALTH; HEALTH CARE UTILIZATION; HEALTH STATUS; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MEDICAL RECORD; NURSE; OUTPATIENT DEPARTMENT; PATIENT COUNSELING; PRIORITY JOURNAL; QUESTIONNAIRE; SECONDARY PREVENTION; THORAX PAIN; UNITED KINGDOM;

EID: 0032499471     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.316.7142.1434     Document Type: Article

References (19)

1. Moher M, Schofield T, Weston S, Fullard E. Managing established coronary heart disease. BMJ 1997;314:69-70.
2. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. 1. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308:81-106.
3. Browner WS, Hulley SB. Clinical trials of hypertension treatment: implications for subgroups. Hypertension 1989;13(suppl. 1):151-6.
4. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian simvastatin survival study (4S). Lancet 1994;344:1383-9.
5. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996;335:1001-9.
6. O'Connor GT, Buring JE, Yusuf S, Goldhaber SZ, Olmstead EM. An overview of randomised trials of rehabilitation with exercise after myocardial infarction. Circulation 1989;80:234-44.
7. Moher M. Evidence of effectiveness of interventions for secondary prevention and treatment of coronary heart disease in primary care. Oxford: Anglia and Oxford Regional Health Authority, 1995.
8. Daly LE. Long term effect on mortality of stopping smoking after unstable angina and myocardial infarction. BMJ 1983;287:324-6.
9. Cupples ME, McKnight A. Randomised controlled trial of health promotion in general practice for patients at high cardiovascular risk. BMJ 1994;309:993-6.
10. Campbell NC, Thain J, Deans HG, Ritchie LD, Rawles JM. Secondary prevention in coronary heart disease: a baseline survey of provision and possibility in general practice. BMJ 1998;316:1430-4.
11. Ware JE. SF-36 health survey-manual and interpretation guide. Boston: Nimrod Press, 1993.
12. Garratt AM, Ruta DA, Abdalla MI, Buckingham JK, Russell IT. The SF 36 health survey questionnaire: an outcome measure suitable for routine use within the NHS? BMJ 1993;306:1440-4.
13. Pryor DB. User's manual. Angina type specification. Bloomington: Health Outcomes Institute, 1993.
14. Pryor DB, Shaw L, McCants CB, Lee KL, Mark DB, Harrell FE Jr, et al. Value of the history and physical in identifying patients at increased risk for coronary artery disease. Ann Intern Med 1993;118:81-90.
15. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70.
16. Cupples ME, McKnight A, O'Neill C, Normand C. The effect of personal health education on quality of life of patients with angina in general practice. Health Educ J 1996;55:75-83.
17. Hale AS. ABC of mental health: anxiety. BMJ 1997;311:1886-9.
18. Hale AS. ABC of mental health: depression. BMJ 1997;315:43-6.
19. Mayou R. Rehabilitation after heart attack. BMJ 1996;313:1498-9.